Floatz logo

Eloxatin

Adjuvant Chemotherapy

Fudan UniversityPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Adjuvant Chemotherapy cohort.

Asset / SponsorPhaseRating
Peg-Rhg-Csf
Shandong University
Phase 4BB
Capecitabine
Fudan University
Phase 3BB
GIMERACIL
Peking University Cancer Hospital & Institute
Phase 3B
Nivolumab
Fundación GECP
Phase 3B
Carboplatin
Fundación GECP
Phase 3B

View all 21 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →